VLA 0.00% $1.75 viralytics limited

"Accelerate Cavatak's progress", great news with FDA's...

  1. 73 Posts.
    lightbulb Created with Sketch. 1
    "Accelerate Cavatak's progress", great news with FDA's accelerate approvals, fast track desigations & priority reviews programs and with Cavatak's safety profile & excellent Keytruda/ Yervoy combinations, faster approval,hopefully.
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.